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Abstract 
Conventional, molecular plant breeding and genetic modifications have been widely used to 
improve crop yield, quality, architecture and plant ability to tolerate abiotic and biotic 
stresses. However, due to the limitations of resources, time and need of more specific 
targeting lead to the new corridor of targeted genome engineering. Genome editing 
technologies involves the use of plethora of enzymatic tools (meganucleases, zinc finger 
nucleases (ZFNs), Transcription Activator Like Effector Nucleases (TALENs) and Clustered 
Regularly Interspaced Short Palindromic Repeat (CRISPR)/Cas9) that has the capability to 
cut at specific sequence. CRISPR/Cas seems to be more promising, efficient and less time 
consuming. All the ongoing efforts and future advances in this technology will accelerate 
both basic and applied research, opening the door to improve a wide variety of agronomic 
traits in crop plants. In this review, efforts have been made to discuss the various 
techniques needed for genome editing while focusing on the recent advances in 
CRISPR/Cas and its applications in crop improvement and therapeutics. 
Keywords: Genome editing; Meganucleases; ZFNs; TALENs; CRISPR/Cas. 
Introduction 
The genetic material in an organism can be modified using various techniques. The conventional techniques of 
mutagenesis produced random mutations leading to unpredictable changes in genetic makeup of the individuals, whereas 
current strategies of genome engineering or genome editing produce site specific/site directed mutations. Homologous 
recombination was used for gene targeting; however, very low frequency of somatic recombination in plants and 
preferential repair of DNA breaks by non-homologous end joining (NHEJ) as well as extensive screening for 
identification of small number of events proved to be its major limitations. Therefore, the technique proved ineffective in 
plants. Recent developments in sequence specific endonucleases to introduce double strand breaks at the target loci of 
interest have resulted into highly precise genome editing tools, thereby initiating a new era of targeted genome 
engineering having applications in basic and applied research including biomedical and agricultural research.        
Genome editing is a type of genome engineering in which DNA is inserted, replaced, inactivated or removed from a 
genome using artificial engineered nucleases or “molecular scissors”. With the development of sequence specific 
nucleases efficient genome editing tools has been developed. The first genome editing tool that was used to create 
dsbreak in plant was Homing endonucleases (Gao et al., 2010; Antunes et al., 2012), a type of meganucleases which 
modify their target recognition sequence through protein engineering. Meganucleases are endo-deoxyribonucleases 
having a large recognition site (approximately 12-40bp) which makes them perfect tools for engineering genomes in 
bacteria, plants and animals. They are considered to be the naturally occurring restriction enzymes. Meganucleases are 
divided into five families based on their sequence and structure motifs. These are GIY-YIG, HNH, His-Cys box, PD-
(D/E) XK and LAGLIDADG. Among all these LAGLIDADG proteins are used to design meganucleases. These proteins 
exhibit one of the two primary activities, they either function as RNA maturases involved in splicing of their own introns 
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or they function as highly specific endonucleases capable of recognizing and cleaving the exon- exon junction sequence. 
The endonuclease I-SceI is the most prominently used homing endonuclease in yeast to create dsbreak (Paques et al., 
2007). However, the DNA-binding and nuclease domains of homing endonucleases overlap each other and thus are 
difficult to engineer to target different DNA site(s) (Paques et al., 2007). In addition, homing endonucleases recognition 
sites do not occur naturally in the plant genome and the need to incorporate them as a genome engineering tool limits the 
scope of these endonucleases. Despite having certain limitations they have advantages of being very specific and less 
toxicity (off-target is less). 
To overcome the drawbacks of meganucleases, Pavletich and Pabo in (1991) introduced Zinc Finger nucleases (ZFNs). 
For ten years, ZFN’s constituted the predominant genome targeting technology. A ZFN consists of DNA binding domain 
fused with nuclease domain of the FokI endonucleases (Weinthal et al., 2010; Caroll et al., 2011; Voytas et al., 2013). A 
single zinc-finger unit consists of three or four binding modules and each finger recognizes a nucleotide triplet. The DNA 
binding domain consist of eukaryotic transcription factor Cis2 His2 zinc finger domain which approximately consist of 30 
amino acids in a conserved ββ’α configuration. The second domain is cleavage domain which consists of FokI restriction 
enzyme and must dimerize in order to cleave the target sequence of 18-24 bp sequence with a 5–6 bp gap between them. 
Many plants like Arabidopsis, tobacco, maize and soybean have been used for gene targeting for efficient and heritable 
mutagenesis (Shukla et al., 2009; Townsend et al., 2009, Osakabe et al., 2010; Zhang et al., 2010;Curtin et al., 2011). 
However, overtime drawbacks in ZFNs based genome editing, including off-target cleavage due to non-specific binding 
of zinc-finger motifs, have been reported (Weinthal et al., 2010; Caroll et al., 2011; Voytas et al., 2013). Moreover, 
certain nucleotide triplets could not be targeted and interactions within a zinc finger array reduced specificity. 
The DNA-binding domain of the Xanthomonas transcriptional activator-like effector (TALE) protein has also been fused 
with the FokI endonuclease domain to obtain Transcription activator like effector nucleases (TALENs) (Bogdanove et 
al., 2011; Weber et al., 2011; Shan et al., 2013;Feng et al., 2014). The TALEs are composed of variable copies of 33–35 
amino acid repeats. In each repeat, two residues at positions 12 and 13, termed repeat-variable di-residues, determine 
pairing with one base of the target DNA sequence (Streubel et al., 2012). The off-target effects of TALENs are fewer 
than those of ZFNs due to the longer target recognition sites (Weber et al., 2011; Shan et al., 2013; Feng et al., 2014). 
Efficient gene targeting has been reported in various plants (Brachypodium, rice, tobacco and wheat) using TALENs 
(Mahfouz et al., 2011; Shan et al., 2013; Wang et al., 2014). However, the construction of amino acid repeat arrays to 
assemble multiple repeat sequences remains a daunting task. Different methods have been developed to facilitate the 
assembly of repeat arrays and various computer programs are available for efficient TALE designing and target 
prediction (Weber et al., 2011; Shan et al., 2013; Feng et al., 2014). TALE libraries are available for mammalian systems 
(Feng et al., 2014) and the same may be generated for plants as well. TALENs have capability to precisely and quickly 
alter genes and hence hold great promise in biological research including curing genetic disorders. However, the 
construction of amino acid repeat arrays to assemble multiple repeat sequences and sophisticated design and assembly of 
individual DNA-binding proteins for each DNA target sequence remains a difficult task. 
Recently, a new method based on the bacterial CRISPR (clustered regularly interspaced short Palindromic repeats)/Cas 
(CRISPR-associated) type II prokaryotic adaptive immune system has emerged as a powerful alternative method for 
genome engineering (Sorek et al., 2013). Bacterial cells use a single endonuclease, a CRISPR-associated protein, Cas9, 
to provide defence against invading viral and plasmid DNAs. Cas9 forms a complex with a synthetic single-guide RNA 
(sgRNA) which consists of a fusion of CRISPR RNA (crRNA) and trans-activating crRNA. The sgRNA guides Cas9 to 
recognize and cleave target DNA. In this review various aspects of CRISPR/Cas, its function, mechanism and various 
applications in crop improvement and therapeutics have been discussed keeping in view the latest developments in the 
field. 
CRISPR/Cas System 
The latest technology for genome editing is based on RNA-guided engineered nucleases- CRISPR/Cas. CRISPR is a 
segment of prokaryotic DNA containing short repetitions of base sequences. Each CRISPR locus acquires ‘spacer’ that is 
separated by repeat sequences. Cas (CRISPR associated proteins) codes for proteins related to CRISPR. This technology 
holds great promise due to its simplicity, efficiency and versatility. CRISPR/Cas systems are part of the adaptive immune 
system of bacteria and archaea, protecting them against invading nucleic acids such as viruses by cleaving the foreign 
DNA in a sequence-dependent manner. The CRISPR/Cas targets either the DNA or RNA of invading pathogen (Hale et 
al., 2009; Wiedenheft et al., 2009). The type II clustered regularly interspaced short palindromic repeat (CRISPR)/Cas9 
(CRISPR-associated) system from Streptococcus pyogenes is the most widely used system (Jinek et al., 2012). 
The type II CRISPR–Cas system recognizes and targets the genetic material of pathogens via three stepwise processes 
namely acquisition, expression and interference (Van der Oost et al., 2009; Garneau et al., 2010; Horvath et al., 2010; 
Marraffini et al., 2010; Kumar et al., 2015) (Figure 1): (a) Acquisition: This step involves recognition and integration of 
foreign DNA as spacer within the CRISPR locus. The protospacer contains PAM sequence (Protospacer adjacent motifs) 
of 3 nucleotides which acts as recognition motif for acquisition of the DNA fragment (Garneau et al., 2010); (b) 
Expression: In the second step of CRISPR/Cas system the pre-CrRNA is transcribed from the CRISPR locus and 
                                                                                                                                                                    ISSN: 2456-6527                                                                                                                                                      
                               sjrabeditor@scischolars.com              Online Publication Date: January 27, 2018                Volume 3, No. 1 
 Volume 3, No. 1 available at https://www.scischolars.com/journals/index.php/sjrab  123                                                                                           
processed into CrRNA with the help of Cas proteins (Cas1, Cas2, Cas9 and Cas4/Csn2) and tracr RNA molecule. Tracr 
RNA is also involved in processing of CrRNA in Streptococcus pyogenes (Karyelis et al., 2013). The tracer RNA pairs 
with the repeat region of CrRNA via base complementarity and facilitates the processing of pre CrRNA into CrRNA 
(Deltcheva et al., 2011). The processed CrRNA enter into the CRISPR-associated complex for antiviral defence 
(CASCADE) where it recognizes the specific target region of the foreign DNA (Deltcheva et al., 2011); and (c) 
Interference: In this step, the CRISPR/Cas complex forms and targets the specific region of foreign DNA for cleavage it 

















Figure 1 Diagrammatic representation showing recognition and targeting by CRISPR-Cas system 
(adopted from Kumar et al., 2014). 
History of CRISPER/Cas System 
The first description of a CRISPR was given by Ishino et al., 1987 who discovered a group of 29-nucleotide repeats 
divided by non-repetitive short sequences in E. coli, which are now known as spacers. Mojica et al., 2000 later found that 
similar sequences of short regularly spaced repeats (SRSRs) are present in many species of bacteria and archaea. Jansen 
et al., 2002 further elaborated these SRSRs as a group of repeats that is preceded by both a ‘leader’ sequence and an AT-
rich region. The authors also found a conserved family of genes that generally exist near the repeats. This family 
consisted of genes encoding proteins like DNA helicases (cas3) and exonucleases (cas4), which implied that Cas genes 
are likely to have function in DNA metabolism. Jansen et al., 2002, as suggested by Mojica et al., 2000, renamed the 
SRSRs as CRISPRs and the genes found near them as CRISPR-associated (Cas) genes. 
Bolotin et al., 2005 sequenced the CRISPR spacers of 24 strains of Streptococcus thermophilus and Streptococcus 
vestibularis and found that the sequences were homologous with extra-chromosomal elements. They theorized that 
CRISPR spacers are the heritable remnants of exogenous DNA from infecting phages and plasmids. Furthermore, they 
found that phage sensitivity is related to the number of spacers in the CRISPR locus. Therefore, the authors believed that 
spacers give rise to anti-sense RNA which promotes an immune response against exogenous DNA. Like Jansen et al., 
2002; Bolotin et al., 2005 also concluded that CRISPRs were likely involved in DNA degradation. Marakova et al., 2006 
discussed the idea that CRISPR based immunity could be functional through a mechanism analogous to RNAi. 
Barrangou et al., 2007 concluded that the sequence identity of CRISPR spacers must match sequences in a phage genome 
in order to induce CRISPR-based immunity. Moreover, they found that new spacers are integrated into CRISPR loci 
during phage infection. crRNAs recognize the “protospacer” sequences of complementary invasive plasmids. crRNAs in 
many bacterial species have been shown to recognize DNA targets. In an experiment on Staphylococcus epidermidis, 
Marraffini et al., 2008 tested the level of CRISPR immunity when the bacterial cells were infected with a plasmid in 
which a self-splicing intron was inserted into the protospacer so that the intron was present in DNA, but spliced out of 
RNA.  
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Structure of CRISPR/Cas 
The detail structure of CRISPR-Cas system consists of two key elements CRISPR RNAs and Cas proteins. The CRISPR-
RNA consists of two short RNA molecules namely crRNA and trans-encoded CRISPR RNA (tracr RNA). The tracr 
RNA is complementary to and base pairs with a pre-crRNA forming a RNA duplex. This is cleaved by RNaseІІІ, an 
RNA-specific ribonuclease, to form a crRNA/tracr RNA hybrid. These two RNA molecules can be fused artificially to 
form a chimeric RNA molecule termed single guide RNA (sgRNA). Cas proteins are of different types including TypeI 
(Cas1, Cas2, Cas3, Cas5, Cas6 and Cas7 proteins), TypeII (Cas1, Cas2, Cas9 and Cas4 proteins) and TypeIII (Cas1, 
Cas2, Cas6 and Cas10 proteins) (Table 1).  Among them Cas9 endonuclease cleaves at a specific target site with the help 
of CRISPR-RNA. Cas9 and sgRNA together form RNA-guided endonuclease that mediates sequence specific cleavage 
in the genome (Jinek et al., 2012). 
Table 1 List of different types of Cas proteins 
Type Kingdom(organism) Components Function of components Nature of 
target 








Cas1- present in all variants of CRISPR/Cas 
system. It is a metal dependent DNases without 
sequence specificity and is involve in the 
integration of spacer DNA into CRISPR locus 
(Wiedenheft et al., 2009).   
Cas2- protein is also present in all variants of 
CRISPR/Cas system. It is a metal dependent 
endonucleases, but the exact role of this protein is 
still unclear. 
Cas3- protein contains an HD domain, which has 
metal dependent nuclease activity on double 
stranded oligonucleotide (Makarova et al., 2006). 
Cas5 and Cas6- represent distantly related Cas 
proteins, named repeat associated mysterious 
proteins (RAMP’s), which contain atleast one RNA 
recognition motif and a characteristics glycine rich 
loop (Makarova et al., 2006). 
Cas7- subunit of cascade complex  implicated in 
interference, binds CrRNA; if enzymatically active 
might be involved in RNA-guided RNA cleavage 
(Brouns et al., 2008) 
DNA 






Cas1, Cas2,  
Cas9- (formerly Csn1) which is a multifunctional 
protein having the ability to process pre CrRNA 
into CrRNA and induces cleavage at the target site. 
Cas4/Csn2- is a Rec-B like nuclease involved in 
spacer acquition (Makarova et al., 2006). 
 
DNA 
Type III Archaea (Staphylococcus 
epidermis, 




Cas10 and Cas6 
Proteins 
Cas1, Cas2, Cas6 and Cas10-subunit of cascade 
(cmr) complex same as Cas8 but fused to HD and 
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CRISPR/Cas9: Mechanism of Action      
CRISPR/Cas9 is a widely used system for genome editing due to its high degree fidelity and relatively simple 
construction. The crystal structure of Cas9 endonuclease consists of bilobed structure with two nucleic acid binding 
grooves and an adjacent active site (38). The two lobes include a large recognition (REC) lobe connected to a small 
nuclease (NUC) lobe. The REC lobe is a Cas9 specific functional domain and is composed of two domains, REC1 and 
REC2. The NUC lobe consists of two nuclease domains RuvC and HNH and a PAM interacting domain (PI domain) 
(Jinek et al., 2014; Nishimasu et al., 2014; Hsu et al., 2014). The two lobes of Cas9 are connected with each other with 
Bridge helix. Bridge helix is a long alpha helical arginine rich domain which connects the two lobes. Cas9 is a flexible 
protein that cleaves the target DNA in a sequence dependent manner (Nishimasu et al., 2014; Hsu et al., 2014; Sternberg 
et al., 2014). In the absence of nucleic acids ligands, Cas9 is maintained in an auto-inhibition conformation. This auto 
inhibited Cas9 switches to an active form upon guide RNA (sgRNA) loading (Jinek et al., 2014). As soon as guide RNA 
loads on Cas9 endonuclease there is conformational change in the structure and rearrangement of both REC and NUC 
lobes take place to form a central channel where the RNA-DNA heteroduplex will later be positioned (Jinek et al., 2014). 
The guide RNA first interacts with the REC lobe to form a binary Cas9-sgRNA complex (Nishimasu et al., 2014). After 
this interaction, the sgRNA/Cas9 complex scans the target DNA for PAM sequences on the non-complementary DNA 
strand (Jinek et al., 2014). As Cas9 has no energy-dependent helicase activity, PAM recognition has been suggested to 
destabilize the adjacent sequence triggering R-loop formation (Nishimasu et al., 2014; Sternberg et al., 2014). Initial 
cross linking experiments suggested that two unstructured tryptophan-containing flexible loops within the PI domain 
were involved in PAM recognition (Jinek et al., 2014). Recent studies releaved that a major-groove base-recognition 
code for PAM binding where two arginine residues (R1333 and R1335) read out the PAM GG di nucleotides on the non-
complementary strand. Furthermore, interactions of two minor groove lysine and serine residues (K1107 and S1109) 
with the PAM duplex create a K1107-S1109 loop (a ‘phosphate lock’ loop) that connects with the phosphate group of the 
PAM sequence (position +1) in the complimentary strand. This allows the phosphate group to orient the complimentary 
DNA strand for base pairing and hybridization with the guide RNA, leading to separation of DNA strands. The Cas9-
sgRNA complex then probes the flanking DNA for potential guide RNA complementarity (41). Base pairing of matching 
nucleotides at the particular region (8–12 bp) allows step-by-step destabilization of the target DNA and guide RNA-DNA 
heteroduplex formation. As a result, both nuclease domains of the NUC lobe become ready for target cleavage. The 
mobile HNH domain approaches and cleaves the complementary strand in the tertiary complex, whereas the RuvC nicks 
the non-complementary strand (Nishimasu et al., 2014). The structural studies on Cas9 have provided an insight into how 
Cas9 may be engineered to create variants with novel PAM specificities (Figure 2) (Bae et al., 2014).  
 
Figure 2 Diagrammatic representation of the mechanism of CRISPR/Cas (adopted from Belhaj et al., 2015). 
Advantages of the CRISPR/Cas System over Previous Techniques: CRISPR/Cas mechanism provides certain 
advantages over the previous existing editing techniques. These advantages are:  
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1) Wide range of target sites: The absence of fingers for all possible DNA triplets in ZFNs is limited by the range 
of targetable sequences. In the CRISPR/Cas system, the only requirement for target site is the 20bp target 
sequence preceeding 5’-NGGPAM.  
2) Easy delivery into cells: Due to the shorter length of sgRNA sequence it is easy to deliver it into cells than the 
ZFN/TALEN which consists of longer sequence.  
3) Single mode engineering: For a single target site, two different ZFN and TALEN proteins must be engineered, 
each consisting of many repetitive ZF and TALE modules, and their construction is time-consuming and 
expensive. By contrast, the CRISPR/Cas system is an RNA-guided genome editing method, so that Cas9 protein 
does not require reengineering for each new target site. Once a target site is selected, only one cloning step is 
required to generate the final constructs carrying sgRNAs. Therefore, the CRISPR/Cas system is much easier to 
engineer than ZFNs or TALENs.  
4) Multiplexing: The target specificity of the CRISPR/Cas system is only dependent on sgRNAs, which are 
encoded by short sequences of ~100 bp, so it is possible to achieve simultaneous multiplex gene editing of plant 
loci by co-transforming multiple sgRNAs. 
Limitations of the CRISPR/Cas System 
There are a few potential limitations of the CRISPR/Cas system for genome editing. 
1) Requirement of PAM sequences: The PAM sequence (5′-NGG) is required downstream of target sites for 
CRISPR/Cas-induced cleavage, which sometimes may limit the range of available targets.  
2) Off-target mutagenesis- Due to presence of homologous sequences in a genome off targeting occurs. To 
minimize off-target effects, it is necessary to monitor the genome-wide presence of such target sequences and to 
avoid selecting target sequences with homology to many other sites.  
Basic Method for Editing Plant Genome using CRISPR/Cas 
In CRISPR/Cas mediated plant genome editing, first step is the selection of target site in the DNA sequence, the selected 
target site must contain the short PAM sequence at its 3’end. The selection of target is the major step and provides a high 
efficiency of mutagenesis with least/no off targets. Many bioinformatics tools and software have been developed and 
published to detect off-target in model organisms (Belhaj et al., 2015; Heigwer et al., 2014; Xiao et al., 2014). Various 
methods have been developed to select a unique sgRNA with high recognition efficiency after consideration of single 
nucleotide polymorphisms, deletion or insertion of nucleotide(s) in the genome (Ma et al., 2013). More recently, 
genome-wide prediction of highly specific sgRNAs, with little or no off-target effects, has been carried out in model crop 
plants (Xie et al., 2014). 
After the selection of target site for catalytic action of sgRNA, the next step is the designing of oligonucleotides 
corresponding to the protospacer. The designed oligonucleotide(s) are fused with a DNA fragment encoding the sgRNA 
scaffold and placed under a suitable promoter for optimal expression. The construct formed is then transformed into plant 
cell for expression using suitable delivery method. After that secreening is carried out using either restriction fragment 
length polymorphism or T7E1 assays as described by (Xie et al., 2013). If the desired targeted mutagenesis site is present 
within the restriction enzyme sites, PCR can be used to detech the NHEJ-mediated targeted mutagenesis in the genome. 
The NHEJ-mediated mutation will destroy the restriction enzyme site leading to the amplification of mutated sequence 
only. On the other hand, the T7E1 assay involves amplification of targeted sites from genomic DNA followed by 
treatment with mismatch-sensitive surveyor nuclease (T7E1 enzyme). The enzyme cleaves distorted duplex DNA formed 
via cross-annealing of mutated and wild-type sequence only. However, the restriction enzyme site loss assay is more 
sensitive than the T7E1 assay. The last step is the detection of multiple target efficiency. For that sequencing approach is 
employed. 
Therapeutic Applications of CRISPR/Cas System 
Therapy for HIV 
Human immunodeficiency virus (HIV) is a lentivirus that causes acquired immunodeficiency syndrome (AIDS). HIV 
infection systematically destroys the human immune system. Initially, Zinc Finger Nucleases were utilized to disrupt 
CCR5, a protein necessary for HIV to enter target cells (Holt et al., 2010). However, the CRISPR/Cas9 system could also 
be employed to combat HIV using a different strategy. Instead of targeting CCR5, CRISPRs can be used to disrupt the 
long terminal repeat (LTR) promoter of HIV (Ebina et al., 2013). This LTR is necessary for viral genomic RNA 
transcription. (Ebina et al., 2013). Showed that disruption of the LTR region by a CRISPR system could be accomplished 
in HIV-1 provirus integrated human cell lines (Ebina et al., 2013). HIV integrates itself into the host genome, so while 
retroviral therapies can control HIV, the dormant virus still exists in the host genome. The CRISPR system has the 
unique potential to target the integrated genomic HIV. LTR regions exist on both sides of the integrated HIV genome. 
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Due to this, the CRISPR system can remove the sequence of integrated HIV DNA from the host genomes by cleaving at 
both LTRs (Ebina et al., 2013). This appears, potentially, to be a very promising form of therapy, though it is still at a 
very early stage. Future challenges include determining potential off-target effects, as well as developing a safe and 
effective delivery system. 
Stem Cells Therapy 
Many genetic diseases could be cured by modifying genomic sequences of pluripotent stem cells of patients to express 
wild-type copies of the disease causing genes. This would allow for autologous stem cell therapies which reduces the risk 
of graft-host disease compared to allogenic treatments. For example, Schwank et al, 2013 studied the use of CRISPR 
gene knock-in as a therapy for Cystic Fibrosis. They succeeded in correcting mutant CFTR Delta-F508 alleles (alleles 
with a mutation that causes cystic fibrosis) using the CRISPR/Cas9 mediated homologous recombination in intestinal 
stem cells. Schwank 2013 also showed that the corrected genes could function normally in an organoid system. Other 
studies have revealed that mouse organoids grown in vitro can be successfully transplanted into living mice. Systems like 
this could eventually be used for human stem cell therapy. However, this technique may give rise to the risk of 
endogenous gene disruption and activation of nearby oncogenes. More work must be one to accurately determine and 
reduce the risks of this technique. 
Therapeutic Strategy for Human Papillomavirus (HPV) 
The second most common cancer in women is cervical cancer and the causitive agent of this cervical cancer is high risk 
human papillomavirus (HR-HPV) especially HPV16 and HPV18. Oncogenes E6 and E7 are expressed in the early stage 
of HPV infection and their functions are to disrupt normal cell cycle and to maintain a transformed malignant phenotype 
(Talora et al., 2002; Lee et al., 2002).  For instance, E7 protein binds to cullin 2 ubiquitin ligase complex and leads to the 
ubiquitination and degradation of the retinoblastoma (pRb) tumor suppressor (Chung et al., 2009) and in the absence of 
pRb, the E2F family of transcription factors is released and host cell proliferation is promoted. Therefore, they are 
attractive targets for cancer gene therapy. The CRISPR/Cas system is a newly developed programmable RNA-guided 
endonuclease system which has emerged as a powerful genome editing tool in many organisms including prokaryotes 
such as C. elegans, and zebrafish (Hwang et al., 2013). Consisting of a site-specific single-guide-RNA (sgRNA) and a 
Cas9 enzyme, the system can basically target any genomic site in the form of 5′-N20NGG-3′ CR (56). CRISPR/Cas 
system could disrupt HPV16-E7 DNA at specific sites, inducing apoptosis and growth inhibition in HPV positive SiHa 
and Caski cells, but not in HPV negative C33A and HEK293 cells. Moreover, disruption of E7 DNA directly leads to 
downregulation of E7 protein and upregulation of tumor suppressor protein pRb. Therefore, it was concluded that 
HPV16-E7 gRNA guided CRISPR/Cas system might be used as a therapeutic strategy for the treatment of cervical 
cancer (Zheng et al., 2014). 
Therapeutic Strategy for Retinitis Pigmentosa 
Retinitis pigmentosa (RP) encompasses much different hereditary retinal degeneration that is caused by a vast array of 
different gene mutations and has highly variable disease presentations and severities. This heterogeneity poses a 
significant therapeutic challenge. More recently, gene editing tools using the bacterial clustered regularly interspaced 
short palindromic repeats/ CRISPR-associated protein (CRISPR/Cas) system has opened up new therapeutic avenues that 
can address dominant as well as recessive forms of RP. Coupled with the ability to generate induced pluripotent stem 
cells (iPSCs) from mature cells and to differentiate them into retinal cells, CRISPR brings within reach the possibility of 
autologous iPSC-derived retinal cell transplantation, which might not only halt, but also potentially reverse progressive 
vision loss in RP. At the same time, efficient gene editing would also allow the rapid generation of cell culture and 
animal disease models tailored for the study of particular disease mutations in individual patients (Andrew et al., 2015). 
Application of CRISPR/Cas9 in Plant Breeding  
Conventional plant breeding relies on existing natural genetic variation and extensive back-crossing programs are 
necessary to introgress the selected traits into an elite background. New alleles can be introduced by random 
mutagenesis, but this must be followed by the time consuming screening of large populations to identify mutants with 
desirable properties. To overcome the drawbacks of conventional methods recently genome editing tool CRISPR/Cas9 
can be used to accelerate crop improvement by allowing introduction of precise modification in the elite background. The 
advantage of this method is that multiple traits can be modified simultaneously. Wang et al., 2014 used both TALEN and 
CRISPR/Cas9 technologies to target the genes of the mildew-resistance locus (MLO) in wheat and successfully knocked 
out all three MLO homoeoalleles, generating plants resistant to powdery mildew disease. Site-specific nucleases also 
allow targeted molecular trait stacking, i.e., the addition of several genes in close vicinity to an existing transgenic locus. 
This makes it feasible to introduce multiple traits into crops with a low risk of segregation, which is difficult to achieve 
by classical breeding or even conventional genetic engineering (Ainley et al., 2013). Once stacking has been achieved, 
the entire array of transgenes can be mobilized into other germplasm by crossing because it behaves as a single locus. 
The genome editing technology using CRISPR/Cas has been successfully reported in Arabidopsis (Ainley et al., 2013; Li 
et al., 2013) and Rice (Miao et al., 2013). Recently certain issues in crops such as enhancing the chance of germline 
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transmission from genome-edited mutant lines (Miao et al., 2013; Yan et al., 2015) or DNA-free gene editing (Woo et 
al., 2015) have been examined. Here are some examples to show how genome editing can help to improve crop like 
desired trait knock-in via CRISPR system, DNA free genome edited crops via CRISPR/Cas9 ribonucleoprotein (RNP). 
In vitro pre-assembled CRISPR/Cas9 RNP complexes were delivered successfully to mammalian cells and plant cells 
(Woo et al., 2015; Kim et al., 2014). 
Conclusion and Future Prospectus 
The CRISPR/Cas9 system which is a prokaryotic viral defence system has become one of the most powerful and 
versatile platform for engineering the target genomes. The simplicity and robustness of this system makes it as an 
attractive genome editing tool. The availibility of CRISPR/Cas9 technology will facilitate both forward and reverse 
genetics and enhance basic research. This technology is less time consuming and requires synthesis of short 
oligonucleotide. It provides opportunities for tackling a number of diseases that were beyond the reach of previous 
therapies. Since the dicovery of CRISPR/Cas9 back many reports have been published that means this technology is 
gaining interest in current research. Future studies will most likely attempt to integrate this novel technology into 
modeling various genetic disorders and to examine its safety in preclinical and clinical trials. 
Conflict of Interest 
The authors declare that they have no conflict of interest. 
References 
[1] Ainley, W. M., Sastry-Dent, L., Welter, M. E., Murray, M. G., Zeitler, B., & Amora, R. 
(2013). Trait stacking via targeted genome editing. Plant Biotechnology, 11, 1126–34. 
[2] Andrew, Z., Yaoli, & Stephen, H. (2015). Personalized therapeutics strategies for patients 
with retinitis pigmentosa. Expert opin. Biol. Ther. 15, 391-402. 
[3] Antunes, M. S., Smith, J. J., Jantz, D., &Medford, J. (2012). Targeted DNA excision in 
Arabidopsis by a re-engineered homing endonuclease. BMC Biotech, 12, 86. 
[4] Bae, S., Park, J., &Kim, J. S. (2014). Cas-OFF inder: a fast and versatile algorithm that 
searches for potential off-target sites of Cas9 RNA-guided endonucleases. 
Bioinformatics, 30, 1473–1475. 
[5] Barrangou, R., Fremaux, C., Deveau, H., Richards, M., Boyaval, P., Moineau, S., 
Romero, D. A., &Horvath, P. (2007). CRISPR provides acquired resistance against 
viruses in prokaryotes. Science, 315, 1709–1712.  
[6] Belhaj, K., Angela, C., Sophien, K., Nicola, P., & Vladimer, N. (2015). Editing plant 
genomes with CRISPR/Cas9. Current opinion in biotechnology, 32, 76-84. 
[7] Bogdanove, A. J., & Voytas, D. F. (2011). TAL effectors: customizable proteins for DNA 
targeting. Science, 333, 1843-1846. 
[8] Bolotin A, Quinquis B, Sorokin A, Ehrlich SD. (2005). Clustered regularly interspaced 
short palindrome repeats (CRISPRs) have spacers of extra-chromosomal origin. 
Microbiology, 51, 2551–2561.  
[9] Brouns, S. J., Jore, M. M., Lundgren, M., Westra, E. R., Slijkhuis, R. J., Snijders, A. P., 
Dickman, M. J., Makarova, K. S., Koonin, E. V., van der Oost, J. (2008). Small CRISPR 
RNAs guide antiviral defense in prokaryotes. Science, 321, 960–964. 
[10] Carroll, D. (2011). Genome engineering with zinc-finger nucleases. Genetics, 188:773-
782. 
[11] Chung, C. H., & Gillison, M. L. (2009). Human papillomavirus in head and neck cancer: 
its role in pathogenesis and clinical implications. Clinical Cancer Research, 15, 6758–
6762. 
[12] Curtin, S. J., Zhang, F., Sander, J. D., Haun, W. J., Starker, C., Baltes, N. J., Reyon, D.,  
Dahlborg, E. J., Goodwin, M. J., Coffman, A. P., Dobbs, D., Joung, J. K., Voytas, D. F., 
& Stupar, R. M. (2011). Targeted mutagenesis of duplicated genes in soybean with zinc-
finger nucleases. Plant Physiology, 156,466– 473. 
                                                                                                                                                                    ISSN: 2456-6527                                                                                                                                                      
                               sjrabeditor@scischolars.com              Online Publication Date: January 27, 2018                Volume 3, No. 1 
 Volume 3, No. 1 available at https://www.scischolars.com/journals/index.php/sjrab  129                                                                                           
[13] Deltcheva, E., Chylinski, K., Sharma, C. M., Gonzales, K., Chao, Y., Pirzada, Z. A., 
Eckert, M. R., Vogel, J., & Charpentier, E. (2011). CRISPR RNA maturation by trans-
encoded small RNA and host factor RNase III. Nature, 471, 602–607. 
[14] Ebina, H., Misawa, N., Kanemura, Y., & Koyanagi, Y. (2013) Harnessing the 
CRISPR/Cas9 system to disrupt latent HIV-1 provirus. Science, 3, 2510. 
[15] Feng, Y., Zhang, S., & Huang, X. (2014). A robust TALENs system for highly efficient 
mammalian genome editing. Scientific Reports, 4, 3632. 
[16] Feng, Z., Zhang, B., Ding, W., Liu, X., Yang, D. L., & Wei, P. (2013) Efficient genome 
editing in plants using a CRISPR/Cas system. Cell Resources, 23, 1229–32. 
[17] Gao, H., Smith, J., & Yang H. (2010). Heritable targeted mutagenesis in maize using a 
designed endonucleases. Plant Journal, 61,176–187. 
[18] Garneau, J. E., Dupuis, M. E., Villion, M., Romero, D. A., Barrangou, R., Boyaval, P., 
Fremaux, C., Horvath, P., Magaádan, A. H., & Moineau, S. (2010). The CRISPR/Cas 
bacterial immune system cleaves bacteriophage and plasmid DNA. Nature, 468, 67–71. 
[19] Hale, C. R., Zhao, P., Olson, S., Duff, M. O., Graveley, B. R., Wells, L., Terns, R. M., & 
Tern, M. P. (2009). RNA-guided RNA cleavage by a CRISPR RNA–Cas protein 
complex. Cell, 39, 945–956. 
[20] Heigwer, F., Kerr, G., & Boutros, M. (2014). E-CRISP: fast CRISPR target site 
identification. Nature Methods, 122, 122–123. 
[21] Holt, N., Wang, J., & Kim, K. (2010). Human hematopoietic stem/progenitor cells 
modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo. Nature 
Biotechnology, 28, 839. 
[22] Horvath, P., & Barrangou, R. (2010). CRISPR/Cas, the immune system of bacteria and 
archaea. Science, 327,167–170. 
[23] Hsu, P. D., Lander, E. S., & Zhang, F. (2014). Development and applications of CRISPR-
Cas9 for genome engineering. Cell, 157, 1262-1278. 
[24] Hwang, W. Y., Fu, Y., &Reyon, D. (2013). Efficient genome editing in zebrafish using a 
CRISPR-Cas system. Nature Biotechnology, 31, 227–229. 
[25] Ishino, Y., Shinagawa, H., Makino, K., Amemura, M., &Nakata, A. (1987). Nucleotide 
sequence of the iap gene, responsible for alkaline phosphatase isozyme conversion in 
Escherichia coli, and identification of the gene product. Journal of Bacteriology, 169, 
5429–5433. 
[26] Jansen, R., Embden, J. D., Gaastra, W., & Schouls, L. M. (2002). Identification of genes 
that are associated with DNA repeats in prokaryotes. MolMicrobiol. 2002; 43:1565–1575. 
[27] Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J., & Charpentier, E. (2012). A 
programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. 
Science, 337, 816-821. 
[28] Jinek, M., Jiang, F., Taylor, D. W., Sternberg, S. H., Kaya, E., Ma, E., Anders, C., Hauer, 
M., Zhou, K., & Lin, S., Structures of Cas9 endonucleases reveal RNA-mediated 
conformational activation. Science, 343, 1247997. 
[29] Karvelis, T., Gasiunas, G., Miksys, A., Barrangou, R., Horvath, P., & Siksnys, V. (2013). 
crRNA and tracrRNA guide Cas9-mediated DNA interference in Streptococcus 
thermophilus. RNA Biology, 10, 841–851. 
[30] Kim, H., & Kim, J. S. (2014). A guide to genome engineering with programmable 
nucleases. Nature Review Genetics, 15, 321–334. 
[31] Kumar, V., & Jain, M. (2015) The CRISPR-Cas system for plant genome editing: 
advances and opportunities. Journal of Expt. Bot, 4,462-473. 
[32] Lee, C. J., Suh, E. J., & Kang, H. T. (2002). Induction of senescence-like state and 
suppression of telomerase activity through inhibition of HPV E6/E7 gene expression in 
cells immortalized by HPV16 DNA. Experimental Cell Research, 277,173–182. 
                                                                                                                                                                    ISSN: 2456-6527                                                                                                                                                      
                               sjrabeditor@scischolars.com              Online Publication Date: January 27, 2018                Volume 3, No. 1 
 Volume 3, No. 1 available at https://www.scischolars.com/journals/index.php/sjrab  130                                                                                           
[33] Li, J. F., Norville, J. E., Aach, J., McCormack, M., Zhang, D., & Bush, J. (2013). 
Multiplex and homologous recombination-mediated genome editing in Arabidopsis and 
Nicotianabenthamiana using guide RNA and Cas9. Nature Biotechnology, 31, 688–91. 
[34] Ma, M., Ye, Y. A., Zheng, W. L., Kong, L. (2013). A guide RNA sequence design 
platform for the CRISPR/Cas9 system for model organism genomes, BioMed Research 
International, 2013, 270805- 270809. 
[35] Mahfouz, M. M., Li, L., Shamimuzzaman, M., Wibowo, A., Fang, X., &Zhu, J. K. 
(2011). De novo-engineered transcription activator-like effector (TALE) hybrid nuclease 
with novel DNA binding specificity creates double-strand breaks. Proc. Natl. Acad. Sci. 
USA, 108, 2623-2628. 
[36] Makarova, K. S., Grishin, N. V., Shabalina, S. A., Wolf, Y. I., & Koonin, E. V. (2006). A 
putative RNA-interference-based immune system in prokaryotes: computational analysis 
of the predicted enzymatic machinery, functional analogies with eukaryotic RNAi, and 
hypothetical mechanisms of action. Biol Direct, 1, 7. 
[37] Mali, P., Yang, L., & Esvelt, K. M. (2013). RNA-guided human genome engineering via 
Cas9. Science, 339, 823–826. 
[38] Mao, Y., Zhang, Z., Feng, Z., Wei, P., Zhang, H., Botella, J. R., &Zhu, J. K. (2015). 
Development of germ-line-specific CRISPRCas9 systems to improve the production of 
heritable gene modifications in Arabidopsis. Plant. Biotechnology Journal, (inpress). 
[39] Marraffini, L. A., & Sontheimer, E. J. (2008). CRISPR interference limits horizontal gene 
transfer in staphylococci by targeting DNA. Science, 322, 1843–1845. 
[40] Marraffini, L. A., & Sontheimer, E. J. (2010). CRISPR interference: RNA directed 
adaptive immunity in bacteria and archaea. Nature Review of Genetics, 11,181–190. 
[41] Miao, J., Guo, D., Zhang, J., Huang, Q., Qin, G., &Zhang, X. (2013). Targeted 
mutagenesis in rice using CRISPR-Cas system. Cell Resources, 23, 1233–6. 
[42] Mojica, F. J., Díez-Villasenor, C., Soria, E., & Juez, G. (2000). Biological significance of 
a family of regularly spaced repeats in the genomes of Archaea, Bacteria and 
mitochondria. Molecular Microbiology, 36, 244–246. 
[43] Nishimasu, H., Ran, F. A., Hsu, P.D., Konermann, S., Shehata, S. I., Dohmae, N., 
Ishitani, R., Zhang, F., & Nureki O. (2014). Crystal structure of Cas9 in complex with 
guide RNA and target DNA. Cell, 156, 935-949. 
[44] Osakabe, K., Osakabe, Y., & Toki, S. Site-directed mutagenesis in Arabidopsis using 
custom-designed zinc finger nucleases. Proc. Natl. Acad. Sci. USA, 107, 12034–12039. 
[45] Paques, F., & Duchateau, P. (2007). Meganucleases and DNA double-strand break-
induced recombination perspectives for gene therapy. Current Gene Therapy, 7, 49–66. 
[46] Schwank, G. (2013). Functional repair of CFTR by CRISPR/Cas9 in intestinal stem cell 
organoids of cystic fibrosis patients. Cell Stem Cell, 13, 653–658. 
[47] Shan, Q., Wang, Y., Li, J., Zhang, Y., Chen, K., Liang, Z., Zhang, K., Liu, J., Xi, J. J., 
Qiu, J. L, & Gao, C. (2013). Targeted genome modification of crop plants using a 
CRISPR-Cas system. Nature Biotechnology, 31, 686–688. 
[48] Shukla, V. K., Doyon, Y., & Miller, J. C. (2009). Precise genome modification in the crop 
species Zeamays using zinc finger nucleases. Nature, 459, 437–443. 
[49] Sorek, R., Lawrence, C. M., & Wiedenheft, B. (2013). CRISPR-mediated adaptive 
immune systems in bacteria and archaea. Annual Review Biochemistry, 82,237–266. 
[50] Sternberg, S. H., Redding, S., Jinek, M., Greene, E. C., & Doudna, J. A. (2014). DNA 
interrogation by the CRISPR RNA-guided endonuclease Cas9. Nature, 507, 62-67. 
[51] Streubel, J., Blucher, C., Landgraf, A., & Boch, J. (2012). TAL effector RVD specificities 
and efficiencies. Nature Biotechology, 30,593–595. 
                                                                                                                                                                    ISSN: 2456-6527                                                                                                                                                      
                               sjrabeditor@scischolars.com              Online Publication Date: January 27, 2018                Volume 3, No. 1 
 Volume 3, No. 1 available at https://www.scischolars.com/journals/index.php/sjrab  131                                                                                           
[52] Talora, C., Sgroi, D. C., &Crum, C. P. (2002). Specific down-modulation of Notch1 
signaling in cervical cancer cells is required for sustained HPV-E6/E7 expression and late 
steps of malignant transformation. Genes & Development, 16, 2252–2263. 
[53] Townsend, J. A., Wright, D. A., Winfrey, R. J., Fu, F., & Maeder, M. L. (2009). High-
frequency modification of plant genes using engineered zinc-finger nucleases. Nature, 
459,442–445. 
[54] Vander Oost, J., Jore, M. M., Westra, E. R., Lundgren, M., &Brouns, S. J. (2009). 
CRISPR-based adaptive and heritable immunity in prokaryotes. Trnds. In BiochemSci, 
34,401–407. 
[55] Voytas, D. F. (2013). Plant genome engineering with sequence-specific nucleases. 
Annual Review Plant Biology, 64, 327–350. 
[56] Wang, T., Wei, J. J., Sabatini, D. M., &Lander, E. S. (2014). Genetic screens in human 
cells using the CRISPRCas9 system. Science, 343, 80–84. 
[57] Wang, Y., Cheng, X., Shan, Q., Zhag, Y., Liu, J., Gao, C., & Qiu, J. L. (2014). 
Simultaneous editing of three homoeoalleles in haxaploid bread wheat confers heritable 
resistance to powdery mildew. Nature Biotechnology, 32, 947–951. 
[58] Weber, E., Gruetzner, R., Werner, S., Engler, C., & Marillonnet, S. (2011). Assembly of 
designer TAL effectors by Golden Gate cloning. PLOS ONE, 6, e19722. 
[59] Weinthal, D., Tovkach, A., Zeevi, V., & Tzfira T. (2010). Genome editing in plant cells 
by zinc finger nucleases. Trends. in Plant. Sciences, 15, 308–321. 
[60] Wiedenheft, B., Zhou, K., Jinek, M., Coyle, S. M., Ma, W., &Doudna, J. A. (2009). 
Structural basis for DNase activity of a conserved protein implicated in CRISPR-
mediated genome defense. Structure, 17, 904–912. 
[61] Woo, J. W., Kim, J., Kwon, S., Corvalzan, C., Cho, S. W., Kim, H., Kim, S. G., Kim, S. 
T., Choe, S., & Kim J. S. (2015). DNA-free genome editing in plants with preassembled 
CRISPR-Cas9 Ribonucleoproteins. Nature Biotechnology, 33, 1162-1164. 
[62] Xiao, A., Cheng, Z., Kong, L., Zhu, Z., Lin, S., Gao, G., & Zhang, B. (2014). CasOT: a 
genome-wide Cas9/gRNA off-target searching tool. Bioinformatics, 30, 1180–1182. 
[63] Xie, K., &Yang, Y. (2013). RNA-guided genome editing in plants using a CRISPR–Cas 
system. Molecular. Plant, 6, 1975–1983. 
[64] Xie, K., Zhang, J., & Yang, Y. (2014). Genome-wide prediction of highly specific guide 
RNA spacers for the CRISPR–Cas9 mediated genome editing in model plants and major 
crops. Molecular. Plant, 7, 923–926. 
[65] Yan, L., Wei, S., Wu, Y., Hu, R., Li, H., Yang, W., Xie, Q. (2015). High efficiency 
genome editing in Arabidopsisusing Yao promoter-driven CRISPR/Cas9 system. Mol. 
Plant. (2015) (in press). 
[66] Zhang, F., Maeder, M. L., Unger-Wallace, E., Hoshaw, J. P., & Reyon D. (2010). High 
frequency targeted mutagenesis in Arabidopsis thaliana using zinc finger nucleases. Proc. 
Natl. Acad. Sci. USA, 107, 12028–12033. 
[67] Zheng, H., Lan, Y., Da, Z., Wencheng, D., &Xiaoli, W. (2014). Disruption of HPV18-E7 
by CRISPR/Cas system induces apoptosis and growth inhibition in HPV16 positive 
Human Cervical Cancer cells. Biomed. Res. Int. 2014 (2014) Article ID 612823. 
 
